Ken Fisher's MYGN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 1.21 M shares of Myriad Genetics, Inc. (MYGN) worth $7.42 M, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in MYGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 302,367 shares. Largest reduction occurred in Q4 2019, reducing 119,504 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Myriad Genetics (MYGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Myriad Genetics (MYGN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -71,908 | Reduce 5.62% | 1.21 M | $6.15 |
| Q3 2025 | -15,895 | Reduce 1.23% | 1.28 M | $7.23 |
| Q2 2025 | +219,607 | Add 20.42% | 1.29 M | $5.31 |
| Q1 2025 | +170,006 | Add 18.78% | 1.08 M | $8.87 |
| Q4 2024 | +302,367 | Add 50.16% | 905,209 | $13.71 |
| Q3 2024 | +195,094 | Add 47.85% | 602,842 | $27.39 |
| Q2 2024 | +19,401 | Add 5.00% | 407,748 | $24.46 |
| Q1 2024 | +230,378 | Add 145.84% | 388,347 | $21.32 |
| Q4 2023 | +15,313 | Add 10.73% | 157,969 | $19.14 |
| Q3 2023 | -27,540 | Reduce 16.18% | 142,656 | $16.04 |
| Q2 2023 | -13,828 | Reduce 7.51% | 170,196 | $23.18 |
| Q1 2023 | -6,359 | Reduce 3.34% | 184,024 | $23.23 |
| Q4 2022 | +64,276 | Add 50.97% | 190,383 | $14.51 |
| Q3 2022 | +54,250 | Add 75.50% | 126,107 | $19.08 |
| Q2 2022 | +328 | Add 0.46% | 71,857 | $18.17 |
| Q1 2022 | -14,702 | Reduce 17.05% | 71,529 | $25.21 |
| Q4 2021 | +27,464 | Add 46.73% | 86,231 | $27.60 |
| Q3 2021 | +5,013 | Add 9.33% | 58,767 | $32.30 |
| Q2 2021 | -324 | Reduce 0.60% | 53,754 | $30.58 |
| Q1 2021 | +1,024 | Add 1.93% | 54,078 | $30.46 |
| Q4 2020 | +3,255 | Add 6.54% | 53,054 | $19.77 |
| Q3 2020 | -11,907 | Reduce 19.30% | 49,799 | $13.03 |
| Q2 2020 | +37 | Add 0.06% | 61,706 | $11.34 |
| Q1 2020 | +18 | Add 0.03% | 61,669 | $14.30 |
| Q4 2019 | -119,504 | Reduce 65.97% | 61,651 | $27.23 |
| Q3 2019 | +43,225 | Add 31.34% | 181,155 | $28.63 |
| Q2 2019 | +7,255 | Add 5.55% | 137,930 | $27.78 |
| Q1 2019 | -1,737 | Reduce 1.31% | 130,675 | $33.20 |
| Q4 2018 | +4,141 | Add 3.23% | 132,412 | $29.07 |
| Q3 2018 | +10,185 | Add 8.63% | 128,271 | $46.00 |
| Q2 2018 | +4,797 | Add 4.23% | 118,086 | $37.37 |
| Q1 2018 | -7,023 | Reduce 5.84% | 113,289 | $29.55 |
| Q3 2017 | +59,301 | Add 97.20% | 120,312 | $36.18 |
| Q1 2017 | +1,280 | Add 2.14% | 61,011 | $19.19 |
| Q4 2016 | -32,650 | Reduce 35.34% | 59,731 | $16.67 |
| Q3 2016 | +145 | Add 0.16% | 92,381 | $20.58 |
| Q2 2016 | +2,453 | Add 2.73% | 92,236 | $32.06 |
| Q1 2016 | +8 | Add 0.01% | 89,783 | $38.94 |
| Q3 2015 | +1,725 | Add 1.96% | 89,775 | $37.48 |
| Q1 2015 | -283 | Reduce 0.32% | 88,050 | $35.40 |
| Q4 2014 | +88,333 | New Buy | 88,333 | $34.06 |
Ken Fisher's Myriad Genetics Investment FAQs
Ken Fisher first purchased Myriad Genetics, Inc. (MYGN) in Q4 2014, acquiring 88,333 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Myriad Genetics, Inc. (MYGN) for 45 quarters since Q4 2014.
Ken Fisher's largest addition to Myriad Genetics, Inc. (MYGN) was in Q4 2024, adding 905,209 shares worth $12.41 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 1,207,019 shares of Myriad Genetics, Inc. (MYGN), valued at approximately $7.42 M.
As of the Q4 2025 filing, Myriad Genetics, Inc. (MYGN) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Myriad Genetics, Inc. (MYGN) was 1,294,822 shares, as reported at the end of Q2 2025.